Related Experiment Video

Updated: Aug 29, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

Merlin neutralizes the inhibitory effect of Mdm2 on p53

Hongtae Kim1, Noh-Jin Kwak, Joo Yong Lee

  • 1Neuroscience Genome Research Center, The Catholic University of Korea, 505 Banpo-dong, Socho-gu, Seoul 137-701, Korea.

The Journal of Biological Chemistry
|December 18, 2003
PubMed

Insights

Merlin, a tumor suppressor, enhances p53 stability by blocking Mdm2-mediated degradation. This finding offers potential therapeutic strategies for cancers with non-functional merlin or Mdm2 overexpression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Biology

Background:

  • p53 tumor suppressor stability is regulated by Mdm2 through ubiquitination and proteasomal degradation.
  • c-Abl and PTEN are known to stabilize p53 by inhibiting Mdm2-mediated degradation.
  • The interaction between p53, merlin, and Mdm2 remains to be fully elucidated.

Purpose of the Study:

  • To investigate the correlation between p53 and merlin (NF2-related tumor suppressor) concerning Mdm2 function.
  • To determine if merlin influences p53 stability and transcriptional activity.
  • To explore the therapeutic potential of merlin in cancer treatment.

Main Methods:

  • Western blotting to assess protein levels and stability.
  • Immunoprecipitation assays to study protein interactions.
  • Reporter assays to measure p53 transcriptional activity.
  • Cell viability assays to evaluate merlin-induced apoptosis.

Main Results:

  • Merlin significantly increased p53 stability by inhibiting Mdm2-mediated degradation.
  • Merlin enhanced p53-dependent transcriptional activity.
  • The N-terminal region of merlin was identified as crucial for this activity.
  • Merlin overexpression induced p53-dependent apoptosis in response to serum starvation or chemotherapy.

Conclusions:

  • Merlin acts as a positive regulator of p53 tumor suppressor activity.
  • Merlin stabilizes p53 through Mdm2 degradation.
  • These findings suggest merlin as a potential therapeutic target for tumors with merlin deficiency or Mdm2 overexpression.

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...